An AI tool using stimulated Raman histology can predict sites of glioblastoma recurrence before they appear on MRI.
Key Details
- 1AI model combines imaging, clinical, and molecular data to predict glioblastoma recurrence locations.
- 2Developed using 300 samples from 60 patients; validated on 100 samples from 20 patients.
- 3Utilizes stimulated Raman histology (SRH) to produce rapid, dye-free microscopic images of brain tissue.
- 4AI-based tumor infiltration score matched conventional pathology in predicting recurrences.
- 5Combined model outperformed individual methods, distinguishing tissue likely to recur within 5-10mm accuracy.
- 6Findings published in Science Advances by UC San Francisco and University of Michigan.
Why It Matters
Early and accurate prediction of glioblastoma recurrence sites enables more targeted therapies and may improve patient outcomes. This research highlights the growing synergy between rapid intraoperative imaging and AI for real-time decision-making in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
MSKAI Unveils AI Tool for Embryo Cell Analysis and Imaging-Driven Cancer Insights
MSK researchers employ AI and advanced imaging to reveal cancer mechanisms and track embryonic development at the single-cell level.
•EurekAlert
AI-Driven Home Sensors Enable Privacy-Preserving Health Emergency Detection
Researchers have developed an AI-powered home monitoring system using radar and thermal sensors to detect health emergencies and support elderly independent living.
•EurekAlert
New Study Urges 'Green AI' Practices in Medical Imaging and Healthcare
A new review highlights the urgent need for sustainable AI practices in healthcare, with emphasis on environmental impacts from applications like medical imaging.